Executive Director, Therapeutic Area (TA) Strategy - Neuroscience

Your responsibilities include, but not limited to:  

• Develop TA Strategy to inform pipeline and portfolio decision-making.
• Define and drive mid-and-long term portfolio strategy, goals, strategic objectives and leadership aspiration within TA and DAs in collaboration with other functions within Strategy & Growth (S&G), US and International commercial units, Biomedical Research, and Development.
• Provide early commercial insights to the early phase project teams, with clearly defined deliverables for the commercial transition to US and International teams.
• Develop forecasts and other commercial models for assets in early R&D
• Support the Therapeutic Area Leadership team (TAL) as the Enterprise strategic body that owns the TA Strategy and reviews all programs at Toll Gate transitions.
• Orchestrate stakeholder alignment around updates to the strategy as needed, e.g., due to internal or external market events.
• Identify potential pipeline gaps and make recommendations to address with other S&G functions, US, International, Biomedical Research, and Development
• Collaborate closely with key stakeholders (e.g., US, International, Biomedical Research, Development, and other functions such as Value & Access and US Market Access) to facilitate portfolio decision making in the context of our goal of becoming a top 5 Pharma player in the US while maintaining our international leadership.

What you’ll bring to the role:

• Bachelor Degree required. Advanced degree (PhD, MD or other advanced University degree) or equivalent experience in life science/healthcare; MBA or consulting or equivalent experience highly desirable
• At minimum 10+ years experience gained in Pharma Industry with a strong Scientific or medical background. Experience in Research & Development and/or Commercial functions with experience conducting, commissioning, analyzing primary research. Demonstrated experience Consulting for New products planning. Demonstrated Therapeutic Area (TA) knowledge (or track record to acquire required TA expertise effectively and rapidly). Experience of strategy development and asset shaping early in lifecycle (any functional perspective).
• Highly agile having the capacity to manage several strategic Disease Areas (Das) within a TA and multiple programs internal and external. Substantial experience evaluating new product opportunities through M&A, BD&L, and internal research programs. Highly analytical with the ability to lead and thrive in high challenging environment.
• Experience of strategy development and asset shaping early in lifecycle (any functional perspective). US market experience through brand teams, market access, or consulting.
• Effective and persuasive communicator with strong presentation, communication (both written and verbal), influencing and negotiation skills
• Travel: ability to travel domestically and internationally, to be determined based on business needs  

Desirable:

• Familiarity with financial modelling and business development a plus.

The pay range for this position at commencement of employment is expected to be between $233,600 to $350,400 per year; however, while salary ranges are effective from 1/1/24 through 12/31/24, fluctuations in the job market may necessitate adjustments to pay ranges during this period.  Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills, and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.